Bronchiolitis obliterans syndrome after lung transplantation: Medical treatment

Monaldi Archives for Chest Disease

Volumn 55, Issue 2, 2000, Pages 140-145

  Verleden, G M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Chronic rejection; Lung transplantation; Obliterative bronchiolitis

Indexed keywords

AZATHIOPRINE; BUDESONIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

BRONCHIOLITIS; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; POSTOPERATIVE INFECTION; REVIEW; RISK FACTOR;

EID: 0034063670     PISSN: 11220643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Cooper JD, Billingham M, Egan T, et al. - A working formulation for the standardisation of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713-716.
2. Reichenspurner H, Girgis RE, Robbins BC, et al. - Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1996; 62: 1467-1473.
3. Van Raemdonck D, Verleden G, Vanhaecke J, et al. - The current status of lung transplantation. Acta Chir Aust (in press).
4. Valentine VG, Robbins RC, Berry GJ, et al. - Actuarial survival of heart-lung and bilateral lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996; 15: 371-383.
5. Patterson GM, Wilson S, Whang JL, et al. - Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 1996; 15: 175-181.
6. Bassiri AG, Girgis RE, Doyle RL, Theodore J. - Detection of small airway dysfunction using specific airway conductance. Chest 1997; 111: 1533-1535.
7. Chamberlain D, Maurer J, Chaparro C, Idolor L. - Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 1994; 13: 963-971.
8. Kramer MR, Stoehr C, Wang JL, et al. - The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J Heart Lung Transplant 1993; 12: 675-681.
9. Fisher AJ, Gabbay E, Small T, Doig S, Dark JH, Corris PA. - Cross sectional study of exhaled nitric oxide levels following lung transplantation. Thorax 1998; 53: 454-458.
10. Verladen GM, Dupont LJ, Lamont J, et al. - Is there a role for measuring exhaled nitric oxide in lung transplant recipients with chronic rejection? J Heart Lung Transplant 1998; 17: 231-232
11. Ross DJ, Marchevsky A, Kramer M, Kass RM. - Refractoriness of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts. J Heart Lung Transplant 1997; 16: 832-838.
12. Kroshus TJ, Kshettry VR, Savik K, Ranjit J, Hertz MI, Bolman RM. - Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 1997; 114: 195-202.
13. O'Hair DP, Cantu E, McGregor C, et al. - Preliminary experience with mycophenolate mofetil used after lung transplantation. J Heart Lung Transplant 1998; 17: 864-868.
14. Ross DJ, Waters PF, Levine M, Kramer M, Ruzevich S, Kass RM. - Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience. J Heart Lung Transplant 1998; 17: 768-774.
15. Zuckermann A, Birsan T, Taghavi S, et al. - Mycophenolate mofetil in lung transplantation. Transplant Proc 1998; 30: 1514-1516.
16. Keenan RJ, Konishi H, Kawai A, et al. - Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg 1995; 60: 580-585.
17. Horning NR, Lynch JP, Sundaresan SR, Patterson GA, Trulock EP. - Tacrolimus therapy for persistent or recurrent acute rejection after lung transplantation. J Heart Lung Transplant 1998; 17: 761-767.
18. Ross DJ, Jordan SC, Nathan SD, Kass RM, Koerner SK. - Delayed development ot obliterative bronchiolitis syndrome with OKT3 after unilateral lung transplantation. A plea for multicenter immunosuppressive trials. Chest 1996; 109 870-873.
19. Reichenspurner H, Robbins R, Miller J, et al. - RATG-induction therapy significantly reduces incidence of acute pulmonary rejection compared to OKT3 treatment. J Heart Lung Transplant 1996; 15: S103.
20. Wiebe K, Harringer W, Wahlers T, et al. - ATG induction therapy and the incidence of bronchiolitis obliterans after lung transplantation: does it make a difference? Transplant Proc 1998; 30: 1517-1518.
21. Valentine VG, Robbins RC, Wehner JH, Patel HR, Berry GJ, Theodore J. - Total lymphoid irradiation for refractory acute rejection in heart-lung and lung allografts. Chest 1996; 109: 1184-1189.
22. Takao M, Higenbottam TW, Audley T, Otulana BA, Wallwork J. - Effects of inhaled nebulized steroids (budesonide) on acute and chronic lung function in heart-lung transplant recipients. Transplant Proc 1995; 27: 1284-1285.
23. Cahill BC, O'Rourke MK, Strasburg KA, et al. - Methotrexate for lung transplant recipients with steroid-resistant acute rejection. J Heart Lung Transplant 1996; 15: 1130-1137.
24. Soghikian MV, Valentine VG, Berry GJ, Patel H, Robbins RC, Theodore J. - Impact of ganciclovir prophylaxis on heart-lung and lung transplant recipients. J Heart Lung Transplant 1996; 15: 881-887.
25. Baudet EM, Dromer C, Dubrez J, et al. - Intermediate-term results after en-bloc double-lung transplantation with bronchial arterial revascularization. J Thorac Cardiovasc Surg 1996; 112: 1292-1300.
26. Yacoub M, Al-Kttan KM, Tadjkarimi S, Eren T, Khaghani A. - Medium term results of direct bronchial arterial revascularization using IMA for single lung transplantation (SLT with direct revascularisation). Eur J Cardiothor Surg 1997; 11: 1030-1036.
27. Norgaard MA, Andersen CB, Pettersson G. - Does bronchial artery revascularization influence results concerning bronchiolitis obliterans syndrome and/or obliterative bronchiolitis after lung transplantation? Eur J Cardiothor Surg 1998; 14: 311-317.
28. Daly RC, McGregor CGA, McDougall JC, Midthun DE, Peters SG, Scott JP. - Bronchial artery revascularization does not prevent bronchiolitis obliterans syndrome after lung transplantation. Proceedings of the 3rd International Congress on Lung Transplantation, Paris, 10-11 September, 1998; p. 22.
29. Glanville AR, Baldwin JC, Burke CM, Theodore J, Robin ED. - Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression. Ann Int Med 1987; 107: 300-304.
30. Ross DJ, Lewis MI, Kramer M, Vo A, Kass RM. - FK 506 rescue immunosuppression for obliterative bronchiolius after lung transplantation. Chest 1997; 112: 1175-1179.
31. Kesten S, Chaparro C, Scavuzzo M, Gutierrez C. - Tacrolimus as rescue therapy for bronchiolitis obliterans syndrome. J Heart Lung Transplant 1997; 16: 905-912.
32. Reichenspurner H, Meiser BM, Kur F, et al. - First experience with FK 506 for treatment of chronic pulmonary rejection. Transplant Proc 1995; 27: 2009.
33. Knoop C, Antoine M, Vachiery JL, Yernault JC, Estenne M. - FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases. Transplant Proc 1994; 26: 3240-3241.
34. Wiebe K, Harringer W, Franke U, et al. - FK506 rescue therapy in lung transplantation. Transplant Proc 1998; 30: 1508-1509.
35. Lipson DA, Palevsky HI, Kotloff RM, Edelman J. - Conversion to tacrolimus (FK506) from cyclosporine alter orthotopic lung transplantation. Transplant Proc 1998; 30: 1505-1507.
36. Whyte RI, Rossi SJ, Mulligan MS, et al. - Mycophenolate mofetil for obliterative bronchiolitis syndrome after lung transplantation. Ann Thorac Surg 1997; 64: 945-948.
37. Dusmet M, Maurer J, Winton T, Kesten S. - Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients. J Heart Lung Transplant 1996; 15: 948-954.
38. Snell GI, Esmore DS, Williams JW. - Cytolytic therapy for the bronchiolitis obliterans syndrome complicating lung transplantation. Chest 1996; 109: 874-878.
39. Kesten S, Rajagopalan N, Maurer J. - Cytolytic therapy for the treatment of bronchiolitis obliterans syndrome following lung transplantation. Transplantation 1996; 61: 427-430.
40. Iacono A, Keenan RJ, Duncan SR, et al. - Aerosolized cyclosporine in lung recipients with refractory chronic rejection. Am J Respir Crit Care Med 1996; 153: 1451-1455.